With conflicting information from federal and state agencies over the past month, we set out to clarify the facts about the ...
A phase 2 study shows that azelastine nasal spray lowered coronavirus infection rates to 2.2% compared to 6.7%, researchers at Germany's Saarland University revealed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback